EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Circulating biomarkers for diagnosis of doxorubicin-induced cardiotoxicity in breast cancer patients: A prospective observational study

Lakshmi V Divya, Ashok Govindaraj, Anita Ramesh Chandra, D Gnanaguru, Abishkauf Jenish Beautlin, S Jayapriya

Indian Journal of Medical Research · 2026

DOI: 10.25259/ijmr_3595_2025 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Indian Journal of Medical Research, 2026. Verfasst von Lakshmi V Divya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Chettinad Academy of Research and Education, Kelambakkam, Chennai, Tamil Nadu, India. Hauptthemen laut MEDLINE: Doxorubicin, Cardiotoxicity, Breast Neoplasms, Biomarkers. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Doxorubicin is an effective chemotherapeutic agent, whose clinical use is limited by cumulative doxorubicin-induced cardiotoxicity. Early identification of myocardial injury is essential to prevent irreversible cardiac dysfunction. This study evaluated changes in cardiac function and circulating biomarkers associated with early doxorubicin-induced cardiotoxicity.

Methods

Left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) were assessed before and after chemotherapy. Circulating biomarkers, including high-sensitivity C-reactive protein (hs-CRP), high-sensitivity troponin I (hs-Troponin I), Interleukin-33 (IL-33), and miR126-3p, were analysed. Associations between biomarkers and echocardiographic indicators of subclinical cardiac dysfunction were evaluated.

Results

Significant reductions in LVEF (65.00±2.17% to 59.50±5.47%) and GLS (−19.04±1.87% to −15.37±1.79%), increased hs-CRP, and moderate elevations in IL-33 and significant reduction of miR126-3p were observed following doxorubicin therapy. There was a significant association between LVEF with hs-Troponin I ( P =0.03) and IL-33 ( P =0.04), whereas between GLS with hs-Troponin I ( P =0.04), IL-33 ( P =0.04), and miR126-3p ( P= 0.006). Among biomarker inter-association, hs-Troponin I was highly significantly associated with IL-33 ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCardiotoxicityBreast NeoplasmsBiomarkersHumansFemaleTroponin IMicroRNAsGlobal Longitudinal StrainC-Reactive ProteinMiddle AgedStroke VolumeInterleukin-33Prospective StudiesVentricular Function, LeftAdult

Stichwörter der Autor:innen

Breast cancerCardiac biomarkersCardiotoxicityDoxorubicinGlobal longitudinal strain

Substanzen

DoxorubicinTroponin IMicroRNAsBiomarkersC-Reactive ProteinInterleukin-33IL33 protein, human

Autor:innen und Institutionen

  • Department of Cardiology, Chettinad Academy of Research and Education, Kelambakkam, Chennai, Tamil Nadu, India.
  • Department of Oncology, Saveetha Institute of Medical and Technical Sciences, Poonamalle, Chennai, Tamil Nadu, India.
  • Department of Cardiology, Chitra Hospita, Rajapalayam, Chennai, Tamil Nadu, India.
  • Department of Cardiology, Tagore Medical College and Hospital, Rathinamangalam, Chennai, Tamil Nadu, India.

Zitieren

APA

Divya, L. V., Govindaraj, A., Chandra, A. R., Gnanaguru, D., Beautlin, A. J., & Jayapriya, S. (2026). Circulating biomarkers for diagnosis of doxorubicin-induced cardiotoxicity in breast cancer patients: A prospective observational study. Indian Journal of Medical Research. https://doi.org/10.25259/ijmr_3595_2025

Vancouver

Divya LV, Govindaraj A, Chandra AR, Gnanaguru D, Beautlin AJ, Jayapriya S. Circulating biomarkers for diagnosis of doxorubicin-induced cardiotoxicity in breast cancer patients: A prospective observational study. Indian Journal of Medical Research. 2026. doi:10.25259/ijmr_3595_2025

BibTeX
@article{Divya2026,
  author = {Divya, Lakshmi V and Govindaraj, Ashok and Chandra, Anita Ramesh and Gnanaguru, D and Beautlin, Abishkauf Jenish and Jayapriya, S},
  title = {Circulating biomarkers for diagnosis of doxorubicin-induced cardiotoxicity in breast cancer patients: A prospective observational study},
  journal = {Indian Journal of Medical Research},
  year = {2026},
  doi = {10.25259/ijmr_3595_2025}
}
Kostenlos starten →